Wed.Jul 15, 2020

article thumbnail

Disprin Direct: uses, side effect of chewable aspirin

Druggist

Disprin Direct is a chewable form of aspirin 300mg tablets. Disprin Direct is placed on the tongue and allowed to disperse without the use of water. Information reviewed in this post: Legal status and availability of Disprin Licensed use Age restrictions Contra-indications: who cannot use Disprin chewable aspirin Recommended dose Possible side-effects Alternative options Disprin Direct legal status The legal status of Dispirin Direct depends on the pack size of the product.

article thumbnail

A Discussion On Artificial Intelligence in Clinical Research and How Studies Can Be More Efficient

Clinical Trial Gurus

AI is positioning itself to improve recruitment strategies and potentially disrupt the clinical research industry. As the guest in this video explains, AI can now review medical records and identify patients that meet study criteria. There is no doubt that there will be a high demand for people who can recruit the patients that the AI identifies as potential study candidates.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Scenic Biotech Awarded €3.1 million Innovation Credit from Dutch Government to Progress CD47/QPCTL Immuno-oncology Program

Drug Discovery Today

Amsterdam, The Netherlands, 23 June 2020 - Scenic Biotech BV (“Scenic”), a pioneer in the discovery of genetic modifiers to enable the development of disease modifying therapeutics for rare genetic disorders and other devastating illnesses, today announced that it has been awarded a €3.1 million Innovation Credit from the Dutch Government. The funds will be used to advance the Company’s lead CD47/QPCTL immuno-oncology program through preclinical development towards human clinical studies.

article thumbnail

Expand your Formulation Capacity for COVID-19 Projects in 6 Months or Less

Syntegon Technology Pharma Blog

article thumbnail

Unlocking Excellence: How Catalent Is Transforming Japan’s Clinical Research

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud